The document outlines guidelines for Good Documentation Practices (GDP) as described in the proposed USP–NF General Chapter <1029>, emphasizing the importance of clear, complete, and accurate records in pharmaceutical manufacturing and testing. It details the principles of documentation, including data collection methods, record integrity, and compliance with regulations. The presentation serves as a resource for pharmaceutical professionals to develop and maintain effective quality systems.